Scope Biosciences
Last verified 2026-06-16. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-01-01attributed |
| Founded | 2020 |
| Headquarters | Wageningen, Netherlands |
| Industry | biotech |
| Stage | unknown |
| Website | scopebio.com |
scopeDx CRISPR-based portable molecular diagnostics for agriculture and healthcare; EIC Transition 2023 SCOPE project
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.7M | undisclosed |
Detected tech stack
@sentry/browser, adobe fonts, afterpay, hsts, moment 0, parallax.js, sentry, spin.js, squarespace, squarespace commerce, stimulus, typekit
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | scopebio.com, read 2026-06-16 |
| Description | self-reported | scopebio.com, read 2026-06-16 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.